The Asco Post

Today in Oncology

Current News from the World of Oncology Last Updated: Monday, August 03, 2015 11:02:22 PM

ERCC1 and Thymidylate Synthase Expression Identified as Promising Biomarke...8/3/2015 1:08:41 PM - Joseph Cupolo

Race and Institutional Support May Play a Role in Pharmacogenomic Trial Pa...8/3/2015 12:57:23 PM - The ASCO Post

Carolyn R. Bo Aldige Reflects on 30 Years of Cancer PreventionJune 10, 2015, Volume 6, Issue 10 - Supplement - Ronald Piana

Modified Mullerian-Inhibiting Substance Suppresses Growth of Some Recurren...8/3/2015 12:37:15 PM - The ASCO Post

Improved Outcomes With Aromatase Inhibitors vs Tamoxifen in Early Breast C...8/3/2015 11:35:16 AM - Matthew Stenger

Louis J. DeGennaro, PhD, Named President and Chief Executive Officer of Th...October 15, 2014, Volume 5, Issue 16 - The ASCO Post

Adjuvant Bisphosphonates May Reduce Bone Recurrence and Breast Cancer Mort...8/3/2015 10:48:26 AM - Matthew Stenger

Genetic Test Predicts Colon Tumor Sensitivity to Radiation Therapy7/31/2015 3:17:41 PM - The ASCO Post

Health-Care Fraud and Abuse: Implications for OncologyMarch 25, 2015, Volume 6, Issue 5 - Z. Kevin Lu, PhD, Brian Chen, JD, PhD, Zaina Qureshi, PhD, MPH, Oliver Sartor, MD, and Charles Bennett, MD, PhD, MPP

Many Young Cancer Patients May Have Limited Awareness of Fertility Preserv...7/31/2015 2:51:30 PM - The ASCO Post

Featured Columnists

Collaborating Toward a Cure Kathy Giusti  

Biosimilars: Questions Remain Richard Boxer, MD, FACS  

Considering Clonality in Precision Medicine Michael Green, PhD  

More Featured Columnists

Expert Opinions

Translating Study Recommendations Into Medicare Coverage Patrick Conway, MD  

ASCO Releases Details of Its Conceptual Framework for Assessing Value in Cancer Care Lowell E. Schnipper, MD  

Deciphering the Genetic Variability of Cancer to Advance Precision Oncology Care David B. Solit, MD  

More Expert Opinions

Meeting News

Obinutuzumab Moves Into Lymphoma Treatment Carfilzomib/Dexamethasone Doubles Progression-Free Survival vs Bortezomib/... Immunotherapy Marches On, Making Headway in Advanced Urothelial Bladder Ca... Novel Enzyme Improves Outcomes in Subset of Patients With Pancreatic Cance... More Meeting News

Journal Spotlight

Early-Phase Studies Show Activity of Novel EGFR Inhibitors Rociletinib and... ASCO Endorses ASTRO Guideline on Definitive and Adjuvant Radiotherapy in L... Adjuvant Ipilimumab Increases Recurrence-Free Survival After Complete Rese... PD-1 Inhibitor Pembrolizumab Active in Advanced NSCLC: Outcomes Better Wit... More Journal Spotlights

Health-Care Policy

NCCS Advocates for Legislation to Establish Medicare Service for Cancer Survivorship Care Planning Translating Study Recommendations Into Medicare Coverage ASCO, ACCC Respond to Repeal of Medicare Sustainable Growth Rate Formula Bombarded With Changes in Health Care and Beyond, Gynecologic Oncologists Prepare for the Challenges Ahead More Health-care Policy

Drugs & Regimens

Novel Enzyme Improves Outcomes in Subset of Patients With Pancreatic Cancer Triple Inhibition May Cripple BRAF-Mutated Colorectal Cancer New Concept for Brain Tumors: Tumor Treating Fields Obinutuzumab Moves Into Lymphoma Treatment More Drugs & Regimens

Oncology Worldwide

Noncommunicable Diseases Are the Leading Cause of Death in Low- and Middle-Income Countries How the International Innovation Grant Is Improving Cancer Care for Women in Myanmar Global Oncology Launches Global Cancer Project Map With NCI Addressing the Global Cancer Burden More Oncology Worldwide

Patient's Corner

My Faith Helped Me Choose a Way Forward With Cancer Building and Adjusting to My Life After Cancer Carpe Diem Cancer Will Always Be Part of My Life More Patient's Corner

More on Twitter